GlassScriptPhysician profile
Kelvin D Higa
NPI 1356304224
$468,755.49
in general payments reported to CMS, 2019-2025
10 companies · $63K in 2025
The $63K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $82K · 2021: $53K · 2022: $82K · 2023: $46K · 2024: $41K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $145K · Food and Beverage: $2,485 · Travel and Lodging: $2,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $144,521.36 |
| Food and Beverage | $2,484.71 |
| Travel and Lodging | $2,353.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $340,756.00 | 2019-2025 | Echelon Flex, Echelon; Endopath, Echelon Circular |
| Covidien LP | $63,021.59 | 2019-2020 | |
| Ethicon INC. | $29,195.43 | 2019-2025 | Echelon Flex, Echelon; Endopath, Echelon Endopath |
| Medtronic, INC. | $10,052.67 | 2021-2023 | Ligasure |
| Ethicon US, LLC | $9,282.54 | 2019-2025 | Echelon Flex, Echelon Endopath, Linx Reflux Management System |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | $8,902.00 | 2019 | |
| Ethicon Endo-Surgery INC. | $6,396.70 | 2024-2025 | Echelon Flex, Echelon; Endopath |
| Karl Storz Endoscopy-America | $839.88 | 2019-2022 | |
| Stryker Corporation | $308.68 | 2019-2023 | 1788 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,800.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelvin Higa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.